284 related articles for article (PubMed ID: 17437493)
1. Cardiac magnetic resonance in Chagas' disease.
Rochitte CE; Nacif MS; de Oliveira Júnior AC; Siqueira-Batista R; Marchiori E; Uellendahl M; de Lourdes Higuchi M
Artif Organs; 2007 Apr; 31(4):259-67. PubMed ID: 17437493
[TBL] [Abstract][Full Text] [Related]
2. Myocardial involvement in Chagas disease: insights from cardiac magnetic resonance.
Regueiro A; García-Álvarez A; Sitges M; Ortiz-Pérez JT; De Caralt MT; Pinazo MJ; Posada E; Heras M; Gascón J; Sanz G
Int J Cardiol; 2013 Apr; 165(1):107-12. PubMed ID: 21907431
[TBL] [Abstract][Full Text] [Related]
3. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity.
Rochitte CE; Oliveira PF; Andrade JM; Ianni BM; Parga JR; Avila LF; Kalil-Filho R; Mady C; Meneghetti JC; Lima JA; Ramires JA
J Am Coll Cardiol; 2005 Oct; 46(8):1553-8. PubMed ID: 16226184
[TBL] [Abstract][Full Text] [Related]
4. [Magnetic resonance imaging in chronic Chagas cardiopathy. Correlation with endomyocardial biopsy findings].
Kalil R; Bocchi EA; Ferreira BM; de Lourdes Higuchi M; Lopes NH; Magalhães AC; Mady C; Pereira Barretto AC; Albuquerque CP; Bellotti G
Arq Bras Cardiol; 1995 Nov; 65(5):413-6. PubMed ID: 8729858
[TBL] [Abstract][Full Text] [Related]
5. Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies.
Shehata ML; Turkbey EB; Vogel-Claussen J; Bluemke DA
Top Magn Reson Imaging; 2008 Feb; 19(1):43-57. PubMed ID: 18690160
[TBL] [Abstract][Full Text] [Related]
6. [Chagas' disease and ischemic stroke].
Carod-Artal FJ
Neurologia; 2006 Apr; 21(3):135-49. PubMed ID: 16575627
[TBL] [Abstract][Full Text] [Related]
7. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy.
Silva MC; Meira ZM; Gurgel Giannetti J; da Silva MM; Campos AF; Barbosa Mde M; Starling Filho GM; Ferreira Rde A; Zatz M; Rochitte CE
J Am Coll Cardiol; 2007 May; 49(18):1874-9. PubMed ID: 17481447
[TBL] [Abstract][Full Text] [Related]
8. Clinical aspects of the Chagas' heart disease.
Punukollu G; Gowda RM; Khan IA; Navarro VS; Vasavada BC
Int J Cardiol; 2007 Feb; 115(3):279-83. PubMed ID: 16769134
[TBL] [Abstract][Full Text] [Related]
9. [Cardiac complications of American trypanosomiasis (Chagas disease). Various case reports and general observations].
Liechti M; Baur HR; Gurtner HP; Straub PW
Schweiz Med Wochenschr; 1990 Oct; 120(41):1493-6. PubMed ID: 2237336
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic].
Gascón J; Albajar P; Cañas E; Flores M; Gómez i Prat J; Herrera RN; Lafuente CA; Luciardi HL; Moncayo A; Molina L; Muñoz J; Puente S; Sanz G; Treviño B; Sergio-Salles X
Rev Esp Cardiol; 2007 Mar; 60(3):285-93. PubMed ID: 17394874
[TBL] [Abstract][Full Text] [Related]
11. Cardiac magnetic resonance imaging in Chagas' disease: a parallel with electrophysiologic studies.
Duran-Crane A; Rojas CA; Cooper LT; Medina HM
Int J Cardiovasc Imaging; 2020 Nov; 36(11):2209-2219. PubMed ID: 32613382
[TBL] [Abstract][Full Text] [Related]
12. Myocardial tissue characterization in Chagas' heart disease by cardiovascular magnetic resonance.
Torreão JA; Ianni BM; Mady C; Naia E; Rassi CH; Nomura C; Parga JR; Avila LF; Ramires JA; Kalil-Filho R; Rochitte CE
J Cardiovasc Magn Reson; 2015 Nov; 17():97. PubMed ID: 26581396
[TBL] [Abstract][Full Text] [Related]
13. Late reactivation of Chagas' disease presenting in a recipient as an expansive mass lesion in the brain after heart transplantation of chagasic myocardiopathy.
Marchiori PE; Alexandre PL; Britto N; Patzina RA; Fiorelli AA; Lucato LT; Rosemberg S; Pereira SL; Stolf NG; Scaff M
J Heart Lung Transplant; 2007 Nov; 26(11):1091-6. PubMed ID: 18022073
[TBL] [Abstract][Full Text] [Related]
14. Chagas' heart disease diagnosed on MRI: the importance of patient "geographic" history.
Marcu CB; Beek AM; van Rossum AC
Int J Cardiol; 2007 Apr; 117(2):e58-60. PubMed ID: 17320218
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).
Marin-Neto JA; Rassi A; Morillo CA; Avezum A; Connolly SJ; Sosa-Estani S; Rosas F; Yusuf S;
Am Heart J; 2008 Jul; 156(1):37-43. PubMed ID: 18585495
[TBL] [Abstract][Full Text] [Related]
16. Chagas' heart disease in Europe: an emergent disease?
Dobarro D; Gomez-Rubin C; Sanchez-Recalde A; Olias F; Bret-Zurita M; Cuesta-Lopez E; Robles-Marhuenda A; Fraile-Vicente JM; Paño-Pardo JR; Lopez-Sendon J
J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1263-7. PubMed ID: 19001935
[TBL] [Abstract][Full Text] [Related]
17. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease.
Bellotti G; Bocchi EA; de Moraes AV; Higuchi M L; Barbero-Marcial M; Sosa E; Esteves-Filho A; Kalil R; Weiss R; Jatene A; Pileggi F
Am Heart J; 1996 Feb; 131(2):301-7. PubMed ID: 8579025
[TBL] [Abstract][Full Text] [Related]
18. Myocardiocyte apoptosis in heart failure in chronic Chagas' disease.
Tostes S; Bertulucci Rocha-Rodrigues D; de Araujo Pereira G; Rodrigues V
Int J Cardiol; 2005 Mar; 99(2):233-7. PubMed ID: 15749181
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic challenges of Chagas cardiomyopathy and CMR imaging.
Belisario Falchetto E; Costa SC; Rochitte CE
Glob Heart; 2015 Sep; 10(3):181-7. PubMed ID: 26407514
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability.
Kwong RY; Korlakunta H
Top Magn Reson Imaging; 2008 Feb; 19(1):15-24. PubMed ID: 18690157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
